UNION CITY, Calif., July 20 /PRNewswire-FirstCall/ -- ABAXIS, Inc.
(Nasdaq: ABAX), a medical products company manufacturing point-of-care blood
analysis systems, has scheduled a conference call for Thursday, July 28, 2005
at 4:15 pm ET to discuss its financial results for the first fiscal quarter
ended June 30, 2005.
Participants can dial (877) 356-5706 or (706) 643-0580 to access the
conference call, or can listen via a live Internet web cast, which can be
found at http://www.abaxis.com. A replay of the call is available by visiting
http://www.abaxis.com for the next 30 days or by calling (800) 642-1687 or
(706) 645-9291, access code 7859242, through August 4, 2005.
About Abaxis
ABAXIS develops, manufactures and markets portable blood analysis systems
for use in any veterinary or human patient-care setting to provide clinicians
with rapid blood constituent measurements. The system consists of a compact,
6.9 kilogram (15 pounds), portable analyzer and a series of single-use plastic
discs, called reagent discs that contain all the chemicals required to perform
a panel of up to 13 tests on veterinary patients and 14 tests on human
patients. The system can be operated with minimal training and performs
multiple routine tests on whole blood, serum or plasma samples. The system
provides test results in less than 14 minutes with the precision and accuracy
equivalent to a clinical laboratory analyzer.
Clint Severson The RCG Group
Chief Executive Officer Joe Dorame, Joe Diaz & Robert Blum
ABAXIS, Inc. 480-675-0400
510-675-6500
SOURCE ABAXIS, Inc.
 back to top
Related links:
http://www.abaxis.com
CONTACT:
Clint Severson, Chief Executive Officer of
ABAXIS, Inc., +1-510-675-6500; or Joe Dorame, Joe Diaz, or Robert
Blum, all of The RCG Group, +1-480-675-0400, for ABAXIS, Inc.
|
